Flux Power Secures Over $3.6 Million Additional eGSE Orders Accelerates its growth in aviation energy solutions with significant new orders, deepening its presence among leading North American airlines VISTA, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, announced today that it has secured more than $3.6 million in additional purchase orders to support a long-standing airline customer. Ranked among the to...
FLUX Power to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference VISTA, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced the Company’s planned participation at the iAccess Alpha Virtual Best Ideas Winter Investment Conference to be held as a virtual event on December 9-10, 2025. Representing the Company, FLUX Power’s CEO, Krishna Vanka, and CFO Kevin Royal will deli...
Flux Power Awarded Patent for Advanced Battery State of Health Technology Driven by a Vision to Deliver Smarter, Longer-Lasting Energy Solutions, Flux Power Integrates AI and Software Intelligence to Meet the Growing Demand for Adaptive, Data-Driven Electrification VISTA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced that the United States Patent and Trademark Office has issued U.S. Patent ...
A director at Galectin Therapeutics Inc sold after exercising options/sold 121,117 shares at 5.470USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's d...
Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update NORCROSS, Ga., Nov. 14, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three and nine months ended September 30, 2025. “The new NAVIGATE data presented at AASLD further strengthen the clinical and mechanistic profile of belapectin. We continue to see encouraging consistency across key biomarkers—including FibroScan®, ELF, and PRO-C3—all ...
Flux Power Reports Fiscal Year 2026 First Quarter Financial Results VISTA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today reported financial and operational results for the 2026 fiscal first quarter ended September 30, 2025. First Quarter and Recent Business Highlights Received $2.4 million in repeat orders from a leading global food and beverage distribution company and a global industrial equipment ...
Flux Power Receives UL EE Listing Across Full Material Handling Portfolio and UL 1973 for 80V GSE Energy Solutions Certifications Position Flux Power to Deliver Smarter, Safer, and More Connected Energy Solutions for Industrial and Aviation Applications. VISTA, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced major certification milestones that reinforce its leadership in safety, reliability, ...
Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting New biomarker analyses from the NAVIGATE trial demonstrated consistent antifibrotic effects of belapectin 2 mg/kgUsing established criteria for clinically meaningful worsening, a lower proportion of patients treated with belapectin 2 mg/kg experienced ≥30% or ≥5 kPa increases in liver stiffness (LSM) by FibroScan® compared with placebo, indicating slowing of fibrosis progression and stabilization of liver functionAcross all ELF fibrosis risk categori...
Flux Power Secures $2.4 Million in Repeat Orders from Major Food & Beverage and Manufacturing Customer Continued growth in material handling electrification highlights increasing demand for sustainable, data-driven energy solutions VISTA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced new purchase orders totaling approximately $2.4 million. The orders include $1.4 million from a leading glob...
Flux Power to Host Fiscal First Quarter 2026 Financial Results Conference Call on November 13, 2025 VISTA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, will report its fiscal first quarter 2026 results on Thursday, November 13, 2025, after market close. Krishna Vanka, Chief Executive Officer, and Kevin Royal, Chief Financial Officer, will host a conference call at 4:30 p.m. ET to discuss the Company’s finan...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Flux Power Announces Pricing of $9.6 Million Underwritten Public Offering VISTA, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (“Flux Power”) (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced the pricing of an underwritten public offering of 3,840,000 shares of its common stock at a public offering price of $2.50 per share, before underwriting discounts and commissions. In addition, Flux Power has granted the underwriter a 30-day option to p...
Flux Power Regains Compliance with Nasdaq’s Continued Listing Requirements VISTA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX) ("Flux Power" or the “Company”), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced that it has received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) confirming it has regained compliance with Nasdaq's continued listing requirements, because its recent market capitalization met Nasdaq's requirement to ha...
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference NORCROSS, Ga., Oct. 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will participate in the H.C. Wainwright 9th Annual MASH Virtual Investor Conference, taking place October 21, 2025. H.C. Wainwright 9th Annual MASH Investor ConferenceCompany presentation: October 21, 2025, at 7:00 AM ETWebcast: The live and archived webcast will also be available on the page in the investors section of ...
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025 NORCROSS, Ga., Oct. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced participation in the AASLD Liver Meeting 2025. The company will deliver two presentations, including one oral and one poster presentation, highlighting data from the NAVIGATE trial assessing belapectin for the treatment of MASH cirrhosis. The meeting will be held November 7-...
Flux Power Reports Fourth Quarter and Fiscal Year 2025 Financial Results Q4 Revenue increased 25% to $16.7 million over Prior Year Period;Fiscal Year 2025 Revenue Up 9% over 2024 VISTA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today reported financial and operational results for the fourth quarter and fiscal year ending June 30, 2025. Fourth Quarter and Recent Business Highlights Secured a purchase ...
Flux Power Closes $5 Million Private Placement of Prefunded Warrants and Common Warrants Strong Participation and Support from Existing Shareholders, Led by Cleveland Capital L.P. VISTA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced that it has entered into securities purchase agreements for the sale of an aggregate of 258,144 Prefunded Warrants and 1,214,769 Common Warrants for gross proc...
Flux Power to Host Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call on September 16, 2025 VISTA, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions for industrial applications, will report its fourth quarter and fiscal year 2025 results on Tuesday, September 16, 2025, after market close. Krishna Vanka, Chief Executive Officer, Kevin Royal, Chief Financial Officer, and Kelly Frey, Chief Revenue Officer, will host a conference call at 4:30 p.m. ET to discuss the Compan...
Flux Power and Averest to Showcase Energy Management and Software Solutions for GSE at the International GSE Expo 2025 in Las Vegas Flux Power and Averest to showcase integrated energy management solutions at the International GSE Expo, highlighting innovations that drive efficiency, sustainability, and smarter ground support operations. VISTA, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leader in advanced lithium-ion energy storage and software solutions for airport ground support equipment (GSE), material handling, and other industrial applic...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.